SCHEMBL24026225

SCHEMBL24026225

COc1ccc2c(c1)[nH]c1ccc3c4ccccc4oc3c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ KDM4E B2RXH2 4/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ MAPT P10636 3/20 0.49
▸ HPGD P15428 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ RAB9A P51151 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ PPARG P37231 1/20 0.48
▸ NCOA2 Q15596 1/20 0.48
▸ NCOA1 Q15788 1/20 0.48
▸ MAOA P21397 3/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ GABRP O00591 1/20 0.47
▸ GABRD O14764 1/20 0.47
▸ GABRA1 P14867 1/20 0.47
▸ GABRB1 P18505 1/20 0.47
▸ GABRG2 P18507 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24026229 0.83 KMT2A (0.49) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL29655467 0.81 GABRA1 (0.51) KDM4EALDH1A1HPGDHSD17B10GABRP
SCHEMBL31846 0.81 GABRA1 (0.51) KDM4EALDH1A1HPGDHSD17B10GABRP
SCHEMBL29819648 0.81 GABRA1 (0.51) KDM4EALDH1A1HPGDHSD17B10GABRP
SCHEMBL19784917 0.81 JAK2 (0.45) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL18646560 0.81 JAK2 (0.45) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL24728587 0.80 JAK2 (0.53) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL4552275 0.80 AHR (0.53) ALDH1A1HPGDGABRPGABRDGABRA1
SCHEMBL14992666 0.80 JAK2 (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL27066955 0.80 JAK2 (0.50) MEN1KMT2APOLBMAOAROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230045531-A1 NOVEL ORGANOMETALLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME SFC CO., LTD. (KR) 2023-02-09 — — US disclosed
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES UNIV ARIZONA STATE (US) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230045531-A1 NOVEL ORGANOMETALLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME ODC1, ORMDL3, ALDH1A2 MEN1 1046/4885KMT2A 919/4885KDM4E 2462/4885
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES PDCD2L, PDCD1, PDCD4 MEN1 1679/4885KMT2A 2798/4885KDM4E 3798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback